Sengenics is a precision medicine company working to improve patient outcomes through physiologically relevant, data-guided decision-making. Our solutions enable the discovery and validation of autoantibody biomarker signatures for patient stratification, drug response prediction, and development of companion diagnostics.
At Biognosys, we believe that proteome insights unfold breakthrough discoveries that can dramatically improve human health. With our versatile portfolio of proprietary next-generation proteomics services, software, and kits, we provide a multi-dimensional view of protein expression, function, and structure in all sample types. Our patented technologies utilize high-resolution mass spectrometry, and through advanced data analytics, we translate data into actionable insights for R&D and clinical research.
Genefirst are a molecular diagnostics company focused on cancer diagnostics and personalised medicine. We offer robust, easy-to-use and sensitive molecular diagnostics solutions to researchers, clinicians and drug companies to enable accurate diagnosis and delivery of safe and effective medicines. Key products include our HPV High Risk genotyping kit (Papilloplex), which does so in a single tube and our ATOM-Seq NGS technologies which includes cancer panels and a custom panel service to support drug development and clinical trials.